Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Summary: B cell depleting therapies (BCDTs) are widely used as immunomodulating agents for autoimmune diseases such as multiple sclerosis. Their possible impact on development of immunity to severe acute respiratory syndrome virus-2 (SARS-CoV-2) has raised concerns with the coronavirus disease 2019...
Main Authors: | Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, Anna Månberg, Sophia Hober, Guro Gafvelin, Hans Grönlund, Peter Nilsson, Mohsen Khademi, Tomas Olsson, Fredrik Piehl, Faiez Al Nimer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004221010464 |
Similar Items
-
Dissecting the Function and Utility of the Humoral Immune Response to SIV in the Non-Human Primate Model of HIV
by: Welles, Hugh Clarke
Published: (2018) -
Expression of Inhibitory Receptors on T and NK Cells Defines Immunological Phenotypes of HCV Patients with Advanced Liver Fibrosis
by: Chisom Ifeoma Adaeze Okwor, et al.
Published: (2020-09-01) -
Using a Vaccine Proposal Assignment to Help Students Synthesize Topics Covered in an Undergraduate Immunology Course
by: Rebecca L. Sparks-Thissen
Published: (2015-08-01) -
PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort [version 1; referees: 2 approved]
by: Colin P. Sharp, et al.
Published: (2017-04-01) -
Implications of Dengue Virus Maturation on Vaccine Induced Humoral Immunity in Mice
by: Connor A. P. Scott, et al.
Published: (2021-09-01)